RT Journal Article
T1 Anti-Inflammatory and Anti-Oxidative Effects of AM404 in IL-1 beta-Stimulated SK-N-SH Neuroblastoma Cells
A1 Apweiler, Matthias
A1 Streyczek, Jana
A1 Saliba, Soraya Wilke
A1 Ditrich, Johannes
A1 Munoz, Eduardo
A1 Fiebich, Bernd L.
K1 AM404
K1 paracetamol
K1 acetaminophen
K1 prostaglandin E-2
K1 8-iso-PGF(2 alpha)
K1 cyclooxygenase
K1 neuroinflammation
K1 oxidative stress
K1 Transport inhibitor am404
K1 Oxidative stress
K1 Acylphenolamine am404
K1 Receptor
K1 Disease
K1 Acid
K1 Neuroinflammation
K1 Acetaminophen
K1 Paracetamol
K1 Pathophysiology
AB An emerging number of studies address the involvement of neuroinflammation and oxidative stress in the pathophysiology of central nervous system (CNS) disorders such as depression, schizophrenia, anxiety, and neurodegenerative diseases. Different cytokines and molecules, such as prostaglandin (PG) E-2, are associated with neuroinflammatory processes. The active acetaminophen metabolite AM404 has been shown to prevent inflammation and neuroinflammation in primary microglia and organotypic hippocampal slice cultures. However, its effects on pathophysiological conditions in the CNS and especially on neurons are still poorly understood. In this study, we therefore evaluated the effects of AM404 and acetaminophen on the arachidonic acid cascade and oxidative stress induced by interleukin (IL)-1 beta in human SK-N-SH neuronal cells. We observed that AM404 and acetaminophen significantly and concentration-dependent inhibited IL-1 beta-induced release of PGE(2), independent of cyclooxygenases (COX)-1 and COX-2 enzymatic activity as well as COX-2 mRNA and protein levels in SK-N-SH-cells. The reduction of IL-1 beta-induced PGE(2)-release by AM404 and acetaminophen treatment might be mediated by the 8-iso-PGF(2 alpha) pathway since IL-1 beta-induced synthesis of this free radical marker is dose-dependently reduced by both compounds, respectively. Therefore, understanding of the potential therapeutic properties of AM404 in neuroinflammation and oxidative stress might lead to future treatment options of different neurological disorders.
PB Frontiers media sa
YR 2021
FD 2021-11-17
LK https://hdl.handle.net/10668/25618
UL https://hdl.handle.net/10668/25618
LA en
DS RISalud
RD Apr 17, 2025